{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:06:05Z","timestamp":1792757165824,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Despite patients with thyroid dysfunction show obvious abnormal hemostatic indicators in the peripheral blood, the current research on whether and how subclinical hypothyroidism (SCH) influence hemostatic function (the coagulation and fibrinolytic system) still remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We conducted this study to evaluate how SCH influence on the coagulation and fibrinolytic system in human body.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Prior to March 2022, Web of Science, Embase, PubMed, WanFang, CNKI data and reference lists were searched to identify eligible researches. Two of us independently extracted the data and evaluated study quality. The effect size is represented by standard mean difference (SMD). Both fixed and random-effects models were used where appropriate. Review Manager 5.3 and STATA 16.0 were used to analyze the eligible data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1325 patients from twelve observational studies were involved in our research. Our study revealed that SCH changed the heamostatic balance towards hypercoagulable and hypofibrinolytic conditions accompanied by an increase in tissue fibrinogen, plasminogen activator and plasminogen activator inhibitor-1. By contrast, there was no statistically difference in acivated partial thromboplastin time (APTT) and D-Dimer in SCH group compared with that in control subjects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study confirmed that SCH is related with a prothrombotic state, as reflected by changes in both coagulation and fibrinolysis. It is highly recommended for screening cardiovascular risk factors in combination with an adequate evaluation of SCH state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p>[<jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/#recordDetails<\/jats:uri>] PROSPERO [CRD42021275313]<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.861746","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:28:39Z","timestamp":1651213719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The Effect of Subclinical Hypothyroidism on Coagulation and fibrinolysis: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qinglei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1611144","article-title":"Subclinical Hypothyroidism","volume":"376","author":"Peeters","year":"2017","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2012.10.070","article-title":"Carotid Intima-Media Thickness in Patients With Subclinical Hypothyroidism: A Meta-Analysis","volume":"227","author":"Gao","year":"2013","journal-title":"Atherosclerosis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/hmbci-2017-0046","article-title":"Association of Prothrombotic Adipokine (Plasminogen Activator Inhibitor-1) With TSH in Metabolic Syndrome: A Case Control Study","volume":"34","author":"Ahirwar","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical Hypothyroidism is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study","volume":"132","author":"Hak","year":"2000","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00777.x","article-title":"Haemostatic Profile in Hypothyroidism as Potential Risk Factor for Vascular or Thrombotic Disease","volume":"31","author":"M\u00fcller","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(03)00408-0","article-title":"Plasma Levels of Free Tissue Factor Pathway Inhibitor in Patients With Various Thyroid Disorders","volume":"110","author":"Ozcan","year":"2003","journal-title":"Thromb Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.2.7221","article-title":"Components of the Fibrinolytic System are Differently Altered in Moderate and Severe Hypothyroidism","volume":"86","author":"Chadarevian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/105072503322511382","article-title":"Hemostatic System as a Risk Factor for Cardiovascular Disease in Women With Subclinical Hypothyroidism","volume":"13","author":"Cant\u00fcrk","year":"2003","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02464.x","article-title":"Blood Coagulation, Fibrinolytic Activity and Lipid Profile in Subclinical Thyroid Disease: Subclinical Hyperthyroidism Increases Plasma Factor X Activity","volume":"64","author":"Erem","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01857","article-title":"Effects of Levothyroxine Treatment on Biochemical and Hemostasis Parameters in Patients With Hypothyroidism","volume":"152","author":"Gullu","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-Analysis of Observational Studies in Epidemiology: A Proposal for Reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"Meta-Analysis Observational Stud Epidemiol (MOOSE) Group JAMA"},{"key":"B12","unstructured":"WellsG\n            SheaB\n            O'ConnellD\n            PetersonJ\n            WelchV\n            LososM\n          Ottawa (ONOttawa Hospital Research InstituteThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses2009"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-07-0496","article-title":"The Effect of Hyperthyroidism on Procoagulant, Anticoagulant and Fibrinolytic Factors: A Systematic Review and Meta-Analysis","volume":"108","author":"Stuijver","year":"2012","journal-title":"Thromb Haemost"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-Analysis in Clinical Trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2307\/2533446","article-title":"Operating Characteristics of a Rank Correlation Test for Publication Bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in Meta-Analysis Detected by a Simple, Graphical Test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.363","article-title":"Global Fibrinolytic Capacity in Patients With Subclinical Hypothyroidism","volume":"52","author":"Guldiken","year":"2005","journal-title":"Endocr J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1160\/TH05-10-0655","article-title":"Haemostatic Function in Subjects With Mild Subclinical Hypothyroidism","volume":"95","author":"Jorde","year":"2006","journal-title":"Troms\u00f8 Study Thromb Haemost"},{"key":"B19","article-title":"Changes and Significance of Serum Lipid and Prethrombotic State Markers in Elderly Women With Subclinical Hypothyroidism","volume":"21","author":"Chen","year":"2009","journal-title":"Modern Pract Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-9455.2014.19.019","article-title":"Value of Platelet Parameters and 4 Coagulation Parameters Subclinical Hypothyroidism Patients","volume":"11","author":"Zhong","year":"2014","journal-title":"Lab Med Clin"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1726","article-title":"Primary and Secondary Hemostasis in Patients With Subclinical Hypothyroidism: Effect of Levothyroxine Treatment","volume":"100","author":"Lupoli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.12102\/j.issn.1672-1349.2018.10.019","article-title":"Clinical Characteristics and Prognosis of Coronary Heart Disease Patients With Subclinical Hypothyroidism","volume":"16","author":"Ren","year":"2018","journal-title":"Chin J Integr Med Cardio-\/Cerebrovascular Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-8640.2018.02.004","article-title":"Clinical Characteristics and Prognosis of Coronary Heart Disease Patients With Subclinical Hypothyroidism","volume":"33","author":"Gao","year":"2018","journal-title":"Lab Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17446651.2020.1738924","article-title":"Treatment of Subclinical Hypothyroidism: Assessing When Treatment is Likely to be Beneficial","volume":"16","author":"Leng","year":"2021","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-165621","article-title":"Von Willebrand Factor to the Rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.06.018","article-title":"Lack of Change in Insulin Levels as a Biological Marker of PAI-1 Lowering in GH-Deficient Adults on R-HGH Replacement Therapy","volume":"124","author":"Di Minno","year":"2009","journal-title":"Thromb Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.21.2241","article-title":"High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor","volume":"98","author":"Th\u00f6gersen","year":"1998","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000018956.63639.7F","article-title":"Fibrinog\u00e8ne Et Risque D'accident Cardio-Vasculaire [Fibrinogen: Factor and Marker of Cardiovascular Risk]","volume":"27","author":"Drouet","year":"2002","journal-title":"J Mal Vasc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2005017","article-title":"Le Fibrinog\u00e8ne a-T-Il Une Place Pour \u00c9valuer Le Risque D'accident Cardiovasculaire Isch\u00e9mique? Is Fibrinogen a Predictor or a Marker of the Risk of Cardiovascular Events","volume":"60","author":"Drouet","year":"2005","journal-title":"Therapie"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.19.7.1776","article-title":"The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly: Results From the Cardiovascular Health Study","volume":"19","author":"Tracy","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/152.5.420","article-title":"Plasma Fibrinogen and Coronary Heart Disease in Urban Japanese","volume":"152","author":"Sato","year":"2000","journal-title":"Am J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001721-200011010-00005","article-title":"Plasma Fibrinogen, Haemostatic Factors and Prediction of Peripheral Arterial Disease in the Edinburgh Artery Study","volume":"11","author":"Smith","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1507\/endocrj.k06-062","article-title":"Elevated Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Antigen Levels in Overt and Subclinical Hypothyroid Patients Were Reduced by Levothyroxine Replacement","volume":"54","author":"Akinci","year":"2007","journal-title":"Endocr J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7306.224","article-title":"Systematic Reviews of Evaluations of Prognostic Variables","volume":"323","author":"Altman","year":"2001","journal-title":"BMJ"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.861746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:29:32Z","timestamp":1651213772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.861746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":34,"alternative-id":["10.3389\/fendo.2022.861746"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.861746","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"861746"}}